Posted from: Thursday, September 18, 2014 - 03:08 PM - Present

Acticlate was Approved for the Treatment of Numerous Infections

July 28, 2014 – The FDA approved Acticlate (doxycycline hyclate) manufactured by Aqua Pharmaceuticals. 

Acticlate is an oral antibiotic approved for the treatment of infections including adjunctive therapy of severe acne.  Acticlate will be available in 75 mg and 150 mg tablets.


Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.

Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval.  Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval.  Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.

*This is provided for information only.  The reference to any medication above does not mean the medication is covered by your plan.


Last Updated Wednesday, November 13, 2019 - 06:36 AM.